Shareholders Challenged FedEx on Abortion Pill Shipments
The board of directors advised investors to reject a resolution requesting a report on the company's distribution risks.
Updated on Sept. 29, 2026 in Public Companies

Live Poll
Should private shipping companies be required to restrict the mailing of legally prescribed abortion medication?
Pro-life shareholders introduced a proposal at the FedEx annual meeting calling for an investigation into legal and reputational risks associated with shipping mail-order abortion medication. The company board responded by recommending a vote against the resolution, citing unnecessary expenses.
Why it matters
The resolution highlights growing pressure on logistics firms to navigate the complex legal landscape of abortion access, as pro-life groups seek to restrict the distribution of medication abortions through commercial carriers.
The shareholder proposal comes as more than 20 states currently maintain laws banning medication abortions. The final results of the vote are expected to be released later this week.
The players
FedEx
FedEx is a global logistics and shipping company that faces increasing scrutiny over its role in the distribution of restricted goods.
Alliance Defending Freedom
The Alliance Defending Freedom is a legal advocacy group that works to influence corporate policies regarding the distribution of abortion pills.
Todd Rokita
Todd Rokita is the Attorney General of Indiana who has actively petitioned shipping companies to cease the transport of abortion medications.
The details
Authored by the Alliance Defending Freedom, the resolution requests that FedEx evaluate the risks of distributing mail-order drugs that may conflict with state-level abortion bans. While the company prohibits the shipment of items such as Kinder Surprise Eggs in the United States, board members argued that this specific proposal constitutes an impractical use of corporate resources.
Timeline
1873: The Comstock Act was passed.
September 28, 2026: Shareholders introduced the resolution at the annual meeting.
Week of September 28, 2026: The resolution vote results are expected to be tallied.
Market Landscape
This move follows a similar proposal introduced at UPS, signaling a broader industry strategy to pressure logistics giants to align with restrictive state laws. The effort is grounded in the historical framework of the Comstock Act of 1873, which previously shaped mailing regulations.
While the immediate impact on customer shipping rates is minimal, the outcome could influence how carriers handle restricted medical deliveries in the future. Shoppers utilizing mail-order pharmacy services in restrictive states may face potential future changes to service availability.
The takeaway
Investors and stakeholders remain divided over the extent of corporate responsibility in enforcing state-level medical regulations. Future advocacy efforts are expected to continue as groups push for greater restrictions on the transport of mail-order abortion drugs.
Further reading
For more insight into corporate governance, visit the Public Companies section.
Live Poll
Should private shipping companies be required to restrict the mailing of legally prescribed abortion medication?










